top of page


By aligning physician, health care facility, non-physician provider, health plan, and patient objectives, NeuroDPM™ provides quality neuroscience teams/services to health plans capable of providing sufficient in-network coverage, while helping to contain costs and maximize patient outcomes and satisfaction.  NeuroDPM™ caps the cost of per capital treatment for a multi-year period and accepts the risk of out-of-network physician services.

Strategic Alignment

  • The health care system is at odds with itself.  Each of the 4 main parties (doctors, hospitals, payers, and patients) benefits in a way that costs the other party something.  Insurers want to spend as little as possible.  Doctors are paid by how much service they provide.  Hospitals want to provide a lot of service without spending on staff or capital equipment. Patient wants to be cured and treated as a person, not a commodity. 


  • The current fee-for-service approach to paying for health care is problematic, since it incentivizes volume over value.  The system encourages each stakeholder to behave in a way contrary to the best needs of the overall system. 


  • NeuroDPM™ has developed methods for assuring strategic alignment so quality, efficiency and cost are optimized to the benefit of all stakeholders.


  • Insurers look to ‘in-network’ service providers to perform medical services at an agreed to price.  Out of network practitioners are able to charge higher rates and the insurer has to pay.  There is a shortage of neuroscience physicians, which often necessitates a patient go out of network to get immediate care.


  • NeuroDPM™'s process increases efficiency and, therefore, availability of neuroscience-oriented treatment for patients reducing network leakage and cost while increasing customer satisfaction.



  • Starting January 1. 2015, certain provisions of the PPACA mandate reimbursement to have a value based component.  This necessitates a whole new type of patient and outcomes tracking.   Reimbursement elements will include effectiveness of treatment, infection rates, re-admission rates, complication rates, and patient satisfaction.  ​


  • NeuroDPM™ has initiated qualitative and quantitative measurements to track outcomes, satisfaction, and cost.  Our neurosurgeons are transitioning to value-based compensation ahead PPACA requirements. Over time, NeuroDPM™ provides trend, benchmarking, and best-practices focus to its clients allowing for additional cost and quality improvements.

bottom of page